Xenon Pharmaceuticals (XENE) PT Lowered to $49 at Wedbush
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Price: $53.46 +2.22%
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Xenon Pharmaceuticals (NASDAQ: XENE) to $49.00 (from $50.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Seiko Group Corp (8050:JP) PT Raised to JPY7,400 at Nomura/Instinet
- Meituan Dianping (3690:HK) (MPNGF) PT Lowered to HK$93 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
